Treatment Potential

Beike stem cell treatment brings promising results to patients all over the world. Beike’s technologies have successfully treated over 200 Type 1, 2 and 3 Ataxia patients. In a recent study of 32 Ataxia patients who received Beike stem cells, 75% see significant improvements within the first month after the stem cell transplant, 47% of the patients see continuing improvements at 6 months, and 38% still see improvements at 12 months after treatment. Overall 78% of the participants in the study report seeing improvements at some point after treatment. Stem cells take time to reach their full efficacy.

Although outcomes vary by the individual, most patients keep the improvements from stem cell therapy for 18-24 months. After which time, the beneficial results of treatment tend to taper off unless a follow-up stem cell treatment is received.

Safe

Beike’s stem cells come from families that donate their child’s umbilical cord after a healthy, full-term birth. The health of the cells is then triple-tested for diseases before being used in stem cell therapy. Umbilical cord stem cells have a proven track-record for safety. Beike’s 6,500+ patients, and returning patients, can attest to the safety of our procedures. The most serious side-effects experienced by our patients are headaches, mild fever and fatigue – similar to that of most over-the-counter medications. Click the button below to have a doctor review your case and receive a prognosis for treatment.